Saturday 17 October 2026
Export LH’s income statement to Excel — free account
Labcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.
318.66
6.41
−1.97%
Follow LH
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
23.80 | 25.80 | 49.48 | 14.66 | 10.98 | 10.96 | 17.26 | 12.46 | 11.25 | 15.73 |
Piotroski F-Score |
8 | 8 | 6 | 5 | 8 | 9 | 6 | 7 | 6 | 5 |
P/S ratio |
1.50 | 1.48 | 1.67 | 1.57 | 1.99 | 1.22 | 1.23 | 0.97 | 1.39 | 1.19 |
Altman Z-Score |
3.02 | 2.75 | 2.91 | 2.75 | 3.55 | 2.84 | 2.33 | 2.37 | 2.29 | 2.28 |
Altman Z″-Score (non-manufacturers) |
3.39 | 3.22 | 2.98 | 3.75 | 4.56 | 3.96 | 2.80 | 3.16 | 2.68 | 2.69 |
P/FCF ratio |
19.40 | 20.05 | 27.50 | 12.20 | 9.41 | 9.49 | 13.56 | 11.31 | 12.02 | 11.98 |
Beneish M-Score |
(2.55) | (2.75) | (2.70) | (2.91) | (2.65) | (2.36) | (2.53) | (2.54) | (2.37) | (2.41) |
P/Operating CF |
33.98 | 24.76 | 34.95 | 28.47 | 37.42 | 21.97 | 24.97 | 22.63 | 25.27 | 24.18 |
Dividend Safety Score |
74 | — | — | — | — | — | — | — | — | — |
P/B ratio |
2.42 | 2.39 | 2.57 | 1.84 | 2.54 | 1.80 | 1.88 | 1.58 | 2.10 | 2.06 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 21.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.83 | 1.78 | 1.96 | 1.97 | 2.29 | 1.56 | 1.77 | 1.47 | 1.97 | 1.70 |
EV/EBITDA |
12.34 | 13.37 | 18.31 | 11.86 | 8.31 | 6.16 | 10.70 | 8.86 | 11.05 | 9.16 |
EV/Operating CF |
15.54 | 14.58 | 17.97 | 11.97 | 9.69 | 10.20 | 14.12 | 12.74 | 13.55 | 13.56 |
EV/FCF |
23.69 | 24.10 | 32.39 | 15.35 | 10.87 | 12.14 | 19.44 | 17.09 | 17.09 | 17.10 |
Quick Ratio |
0.99 | 1.09 | 0.82 | 0.75 | 1.60 | 1.41 | 0.89 | 1.22 | 0.99 | 1.07 |
Current Ratio |
1.42 | 1.44 | 1.17 | 1.50 | 1.92 | 1.66 | 1.12 | 1.51 | 1.25 | 1.36 |
Net Debt/EBITDA |
2.23 | 2.25 | 2.76 | 2.43 | 1.11 | 1.18 | 2.91 | 2.99 | 3.28 | 2.75 |
Debt/Assets |
27.99% | 29.41% | 24.71% | 25.41% | 26.99% | 27.42% | 32.59% | 37.33% | 38.05% | 37.20% |
Debt/Equity |
0.60 | 0.67 | 0.52 | 0.51 | 0.54 | 0.58 | 0.78 | 0.87 | 0.93 | 0.96 |
Asset Turnover |
0.76 | 0.74 | 0.66 | 0.59 | 0.65 | 0.73 | 0.68 | 0.69 | 0.67 | 0.67 |
Operating CF/Net income |
1.87 | 2.13 | 3.18 | 1.53 | 1.31 | 1.37 | 1.75 | 1.48 | 1.22 | 1.68 |
Capex/Depreciation |
(0.63) | (0.76) | (0.78) | (0.80) | (0.58) | (0.31) | (0.68) | (0.60) | (0.58) | (0.50) |
Interest Coverage |
6.18 | 5.22 | 3.64 | 7.99 | 14.39 | 11.79 | 5.53 | 5.43 | 5.55 | 5.80 |
| 10.51% | 9.37% | 4.65% | 12.56% | 24.12% | 18.30% | 11.33% | 12.83% | 19.94% | 13.62% | |
| 4.77% | 4.25% | 2.27% | 6.31% | 11.75% | 8.16% | 4.81% | 5.38% | 7.94% | 5.02% | |
ROIC |
6.54% | 5.69% | 3.95% | 6.03% | 13.32% | 11.22% | 6.34% | 6.58% | 6.36% | 7.66% |
Return on Tangible Assets |
20.49% | 16.50% | 12.11% | 29.47% | 44.33% | 32.58% | 27.81% | 32.77% | 54.42% | 30.04% |
Average Days of Receivables |
59.14 | 58.84 | 62.99 | 61.45 | 82.76 | 78.77 | 63.98 | 59.98 | 65.42 | 58.03 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
15.89% | 17.14% | 16.62% | 14.86% | 12.87% | 12.37% | 14.06% | 13.86% | 14.54% | 14.08% |
Intangible Assets out of Total Assets |
0.56 | 0.54 | 0.57 | 0.46 | 0.57 | 0.58 | 0.66 | 0.70 | 0.69 | 0.69 |
Share Based Compensation of Revenue |
0.90% | 0.90% | 1.06% | 0.98% | 1.01% | 0.80% | 0.93% | 0.81% | 1.06% | 1.15% |
Graham Net Nets |
(0.28) | (0.29) | (0.25) | (0.29) | (0.18) | (0.32) | (0.53) | (0.58) | (0.50) | (0.55) |
Graham Number |
156.75 | 138.55 | 97.78 | 186.38 | 242.40 | 186.56 | 121.01 | 116.08 | 136.10 | 92.31 |
Earnings Yield |
4.20% | 3.88% | 2.02% | 6.82% | 9.11% | 9.12% | 5.79% | 8.02% | 8.89% | 6.36% |
Free Cash Flow Yield |
5.15% | 4.99% | 3.64% | 8.20% | 10.62% | 10.54% | 7.38% | 8.84% | 8.32% | 8.35% |
Revenue per Share |
167.69 | 155.05 | 139.63 | 130.23 | 135.84 | 143.66 | 118.03 | 111.77 | 100.66 | 93.20 |
Operating CF per Share |
19.72 | 18.90 | 15.24 | 21.47 | 32.16 | 21.95 | 14.76 | 12.87 | 14.63 | 11.68 |
Capex per Share |
(5.13) | (5.82) | (5.20) | (4.70) | (3.46) | (3.49) | (4.01) | (3.25) | (3.03) | (2.42) |
Free Cash Flow per Share |
14.59 | 13.09 | 10.04 | 16.77 | 28.70 | 18.46 | 10.75 | 9.62 | 11.60 | 9.26 |
Cash per Share |
6.40 | 18.10 | 6.16 | 3.52 | 15.23 | 13.57 | 3.45 | 4.21 | 3.09 | 4.23 |
Shareholders Equity per Share |
103.60 | 95.97 | 90.41 | 110.83 | 106.24 | 96.98 | 77.29 | 68.75 | 66.45 | 53.72 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
103.60 | 95.97 | 90.41 | 110.83 | 106.24 | 96.98 | 77.29 | 68.75 | 66.45 | 53.72 |
Free Cash Flow |
1,214.00 | 1,097.90 | 874.70 | 1,528.00 | 2,775.40 | 1,795.70 | 1,052.20 | 975.70 | 1,188.20 | 949.00 |
Working Capital |
1,197.00 | 1,476.30 | 540.20 | 1,546.50 | 2,547.60 | 2,046.90 | 325.40 | 956.50 | 548.10 | 651.10 |
Capital Expenditures |
(426.50) | (487.90) | (453.00) | (427.90) | (334.20) | (339.60) | (392.50) | (329.70) | (309.90) | (248.10) |
Net Current Asset Value |
(5,752.40) | (5,520.30) | (5,084.70) | (5,433.50) | (4,781.50) | (5,509.70) | (7,498.20) | (6,378.50) | (7,135.10) | (6,262.50) |
EV/EBIT |
18.41 | 21.28 | 32.88 | 16.30 | 9.88 | 8.90 | 15.34 | 12.55 | 15.56 | 12.77 |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 |
Price to Operating Income |
15.07 | 17.70 | 27.92 | 12.96 | 8.56 | 6.96 | 10.70 | 8.30 | 10.94 | 8.94 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.22 | 0.21 | 0.20 | 0.19 | 0.20 | 0.40 | 0.22 | 0.32 | 0.31 | 0.29 |
Cash ROIC |
8.49% | 7.33% | 6.97% | 9.83% | 16.09% | 11.04% | 7.63% | 7.26% | 8.82% | 8.44% |
Accounts Receivable Turnover |
6.40 | 6.20 | 5.94 | 4.77 | 4.38 | 5.54 | 5.94 | 6.11 | 6.12 | 6.60 |
Accounts Payable Turnover |
11.58 | 11.02 | 10.47 | 11.07 | 12.92 | 14.20 | 13.11 | 13.50 | 13.33 | 13.32 |
Inventory Turnover |
19.34 | 19.39 | 18.61 | 18.70 | 19.75 | 27.03 | 34.45 | 35.12 | 33.38 | 33.82 |
Average Days of Payables |
30.88 | 34.06 | 34.34 | 38.14 | 27.85 | 25.84 | 27.80 | 28.40 | 29.03 | 27.70 |
Days of Inventory on Hand |
19.64 | 19.18 | 19.69 | 21.06 | 17.99 | 17.11 | 10.76 | 10.62 | 11.49 | 11.18 |
Average Receivables |
2,178.85 | 2,097.85 | 2,048.00 | 2,487.80 | 2,997.45 | 2,520.95 | 1,943.80 | 1,854.90 | 1,683.10 | 1,446.60 |
Average Payables |
858.30 | 851.65 | 839.85 | 736.75 | 630.10 | 635.60 | 633.45 | 604.25 | 541.15 | 502.90 |
Average Inventory |
513.95 | 483.90 | 472.60 | 436.00 | 412.30 | 333.95 | 241.00 | 232.25 | 216.20 | 198.10 |
Average Assets |
18,385.85 | 17,552.05 | 18,440.10 | 20,270.25 | 20,228.55 | 19,059.05 | 17,115.85 | 16,429.15 | 15,460.00 | 14,175.85 |
Average Common Equity |
8,336.00 | 7,963.60 | 8,985.80 | 10,185.00 | 9,855.00 | 8,501.80 | 7,269.20 | 6,887.75 | 6,154.95 | 5,225.45 |
Columns are period end dates